OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors
Safa Faraj, E. Helen Kemp, David J. Gawkrodger
Clinical & Experimental Immunology (2021) Vol. 207, Iss. 1, pp. 27-43
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Current Concepts of Vitiligo Immunopathogenesis
Nika Hlača, Tina Žagar, Marija Kaštelan, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1639-1639
Open Access | Times Cited: 34

Baricitinib is Effective in Treating Progressing Vitiligo in vivo and in vitro
Jie Dong, Xuan Huang, Li-Ping Ma, et al.
Dose-Response (2022) Vol. 20, Iss. 2
Open Access | Times Cited: 30

Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo
Emma Guttman‐Yassky, Ester Del Duca, Joel Corrêa da Rosa, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 1, pp. 161-172.e8
Open Access | Times Cited: 19

Oxidative Stress and Phototherapy in Atopic Dermatitis: Mechanisms, Role, and Future Perspectives
Francesco Borgia, Federica Li Pomi, Mario Vaccaro, et al.
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1904-1904
Open Access | Times Cited: 26

The Key of the Terminal Stage of Vitiligo: The Death Form of Melanocytes
Chen Zhang, Yuanyi Gao, Wei Yan, et al.
Dermatologic Therapy (2025) Vol. 2025, Iss. 1
Open Access

A comprehensive outline of the role of non-coding RNAs in vitiligo
Fateme Sadat Feghahati, Soudeh Ghafouri‐Fard
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101916-101916
Closed Access

Vitiligo: Etiology and Pathophysiology
Rawan Almutairi
IntechOpen eBooks (2025)
Closed Access

Clinical patterns of vitiligo in Japan: A descriptive study using the JMDC claims database
Atsushi Tanemura, Yue Ma, Masayo Sakaki‐Yumoto, et al.
The Journal of Dermatology (2025)
Open Access

The Prevalence of Vitiligo Among Patients With Thyroid Diseases
Kaveh Gharaei Nejad, Negin Kamkar, Narges Alizadeh, et al.
Journal of the Dermatology Nurses’ Association (2025) Vol. 17, Iss. 2, pp. 51-55
Closed Access

Emerging Therapeutic Innovations for Vitiligo Treatment
Weiran Li, Penghao Dong, Guanhua Zhang, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 191-191
Open Access

Trained immunity in the pathogenesis of vitiligo
Nicoline F. Post, Greta Ginski, Rens Peters, et al.
Pigment Cell & Melanoma Research (2023) Vol. 36, Iss. 5, pp. 348-354
Open Access | Times Cited: 9

Regenerative Medicine-Based Treatment for Vitiligo: An Overview
Barbara Bellei, Federica Papaccio, Mauro Picardo
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2744-2744
Open Access | Times Cited: 13

Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database
Prethibha George, Oladayo Jagun, Qing Liu, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 9, pp. 1121-1128
Open Access | Times Cited: 7

The relationship between aquaporins and skin diseases
Jiahao Liu, Yingji Jin, Qinqin Wei, et al.
European Journal of Dermatology (2023) Vol. 33, Iss. 4, pp. 350-359
Open Access | Times Cited: 5

Intestinal fatty acid bind protein as a biomarker for vitiligo
Olfat G. Shaker, Samar El‐Tahlawi, Mina A. Fawzy
Journal of the Egyptian Womenʼs Dermatologic Society (2024) Vol. 21, Iss. 1, pp. 52-58
Open Access | Times Cited: 1

Complications of Brentuximab Therapy in Patients with Hodgkin’s Lymphoma and Concurrent Autoimmune Pathology—A Case Series
Oana Diana Preda, Sorina Bădeliță, Iulia Ursuleac, et al.
Hematology Reports (2024) Vol. 16, Iss. 2, pp. 299-307
Open Access | Times Cited: 1

Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo
Yuji Yamaguchi, Elena Peeva, Ester Del Duca, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 7
Open Access | Times Cited: 1

Concurrent Refractory Atopic Dermatitis and Generalized Vitiligo Successfully Treated with Abrocitinib: A Case Report
Xinyi Shao, Xingyu Pan, Yangmei Chen, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 1259-1263
Open Access | Times Cited: 1

Recent trends in the treatment of vitiligo using novel drug delivery system
Nandita Sahu, Parag Jain, Deepika Sahu, et al.
International Journal of Pharmaceutics (2024), pp. 125106-125106
Closed Access | Times Cited: 1

Vitiligo: A Comprehensive Review
A.A. Ebrahim, Samah Ibrahiem, A.A. Elfallah, et al.
Benha Journal of Applied Sciences (2023) Vol. 8, Iss. 2, pp. 93-99
Open Access | Times Cited: 3

Vitiligo: An immune disease and its emerging mesenchymal stem cell therapy paradigm
Meng Zhang, Tingting Xia, Feng-Qin Lin, et al.
Transplant Immunology (2022) Vol. 76, pp. 101766-101766
Closed Access | Times Cited: 5

EGR1 Mediated Reduction of Fibroblast Secreted-TGF-β1 Exacerbated CD8+ T Cell Inflammation and Migration in Vitiligo
Rong Jin, Hao Xu, Miaoni Zhou, et al.
Inflammation (2023) Vol. 47, Iss. 2, pp. 503-512
Closed Access | Times Cited: 2

Vitiligo: concomitant autoimmune and allergic diseases
Marcelina Kądziela, Anna Woźniacka, Elżbieta Dziankowska–Zaborszczyk, et al.
Alergologia Polska - Polish Journal of Allergology (2024) Vol. 11, Iss. 1, pp. 24-30
Open Access

Long Covid, the Gut, and Autoimmune Skin Diseases: A Novel Therapeutic Approach
Patrick Chambers
Neuroscience and Neurological Surgery (2024) Vol. 14, Iss. 1, pp. 01-10
Open Access

Page 1 - Next Page

Scroll to top